These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11257651)

  • 21. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].
    Inoue K; Kuno T; Fukuhara H; Hamaguchi T; Fukata S; Karashima T; Kamada M; Shuin T; Sakakura N; Kasahara K; Watanabe H; Kozai T; Yasuda M; Kataoka S; Tanimura M; Atsushi K; Furihata M
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):661-70. PubMed ID: 19999130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
    Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S
    BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?
    Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
    Urology; 2002 Dec; 60(6):1025-8. PubMed ID: 12475663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
    Stenzl A; Burger M; Fradet Y; Mynderse LA; Soloway MS; Witjes JA; Kriegmair M; Karl A; Shen Y; Grossman HB
    J Urol; 2010 Nov; 184(5):1907-13. PubMed ID: 20850152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic cystoscopy for detection of bladder tumors.
    Kriegmair M; Zaak D; Knuechel R; Baumgartner R; Hofstetter A
    Semin Laparosc Surg; 1999 Jun; 6(2):100-3. PubMed ID: 10459062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
    Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
    J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence detection of bladder tumors with 5-amino-levulinic acid.
    Riedl CR; Plas E; Pflüger H
    J Endourol; 1999 Dec; 13(10):755-9. PubMed ID: 10646684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy.
    Kriegmair M; Zaak D; Stepp H; Stepp H; Baumgartner R; Knuechel R; Hofstetter A
    Eur Urol; 1999 Nov; 36(5):386-92. PubMed ID: 10516447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy.
    Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C
    BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.
    Geavlete B; Jecu M; Multescu R; Georgescu D; Geavlete P
    Urology; 2010 Sep; 76(3):664-9. PubMed ID: 20627289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms.
    Jeon SS; Kang I; Hong JH; Choi HY; Chai SE
    J Endourol; 2001 Sep; 15(7):753-9. PubMed ID: 11697410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
    BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Taoka R; Matsuoka Y; Yamasaki M; Kani N; Honda T; Harada S; Tohi Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Sugimoto M
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102838. PubMed ID: 35381368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
    Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity.
    De Dominicis C; Liberti M; Perugia G; De Nunzio C; Sciobica F; Zuccalà A; Sarkozy A; Iori F
    Urology; 2001 Jun; 57(6):1059-62. PubMed ID: 11377304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?].
    Doisy L; Walz J; Fakhfakh S; Rybikowski S; Koskas Y; Gravis G; Pignot G
    Prog Urol; 2019; 29(6):332-339. PubMed ID: 31104952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
    Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP
    Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.